SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-21-055821
Filing Date
2021-04-28
Accepted
2021-04-27 20:09:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 POS AM tm2114229d3_posam.htm POS AM 572373
2 EXHIBIT 23.1 tm2114229d3_ex23-1.htm EX-23.1 3956
  Complete submission text file 0001104659-21-055821.txt   577498
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: POS AM | Act: 33 | File No.: 333-239923 | Film No.: 21860985
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences